CellWell record HH-147632
Drugs to Slow Progression of Chronic Kidney Disease: It Is a Whole New World!
Jennifer A Schoonmaker; Bhavna Bhasin-Chhabra; Adam Abow Alkhier; Sundararaman Swaminathan; Musab S Hommos
2026
In plain language
RAAS inhibitors, SGLT2 inhibitors, GLP-1 agonists, and non-steroidal mineralocorticoid antagonists reduce chronic kidney disease progression through complementary mechanisms.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-147632
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.